Synthetic enforcement of STING signaling in cancer cells appropriates the immune microenvironment for checkpoint inhibitor therapy | Science Advances
Enforced STING signaling in tumor cells reprograms the TME and sensitizes “cold” tumors to checkpoint inhibitor therapy.